A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Conference Call Scheduled for October 23, 2018at 11:00 am EASTERN DUBLIN, Oct. 16, 2018 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial...
DUBLIN, Ireland, July 19, 2018 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2018. Quarter 2 Results Total...
Conference Call Scheduled for July 19, 2018 at 11:00 am EASTERN DUBLIN, Ireland, July 12, 2018 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report...
DUBLIN, Ireland, June 06, 2018 -- Trinity Biotech plc (Nasdaq:TRIB), today announced that Ronan O'Caoimh, CEO of Trinity Biotech, has increased his shareholding in Trinity Biotech by the acquisition of 430,000 ADRs. As a result of this transaction, Mr. O'Caoimh's...
DUBLIN, Ireland, May 01, 2018 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2018. Quarter 1 Results Total...
Conference Call Scheduled for May 1, 2018 at 11:00 am EASTERN DUBLIN, April 20, 2018 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results...
DUBLIN, Ireland , March 07, 2018 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2017 and fiscal year...
Conference Call Scheduled for March 7, 2018 at 11:00 am EASTERN DUBLIN, Ireland, March 05, 2018 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report...
DUBLIN, Ireland, Oct. 26, 2017 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2017. Quarter 3 Results...
Conference Call Scheduled for October 26, 2017 at 11:00 am EASTERN DUBLIN, Ireland, Oct. 13, 2017 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report 2017...